Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 9357

PubMed (MeSH Keyword) for PubChem Compound (Select 6603770)

1.

[Hodgkin's lymphoma and radiotherapy].

Datsenko PV, Panshin GA.

Vopr Onkol. 2015;61(1):45-51. Russian.

PMID:
26016145
2.

[Nab-Paclitaxel with platinum chemotherapy as sixth-line therapy for a non-small cell lung cancer patient].

Ishiura Y, Shiba Y, Terasaki Y, Hinoue Y, Ishida Y, Segawa M, Saitoh K, Hirokami N, Kasahara K, Fujimura M.

Gan To Kagaku Ryoho. 2015 Apr;42(4):493-5. Japanese.

PMID:
25963700
3.

Tumor homologous recombination deficiency assays: another step closer to clinical application?

Stecklein SR, Sharma P.

Breast Cancer Res. 2014 Jul 14;16(4):409. doi: 10.1186/s13058-014-0409-7.

4.

Primary peritoneal cancer: study of 14 cases and comparison with epithelial ovarian cancer.

Fukuda T, Imai K, Yamauchi M, Teramae M, Hashiguchi Y, Ichimura T, Yasui T, Sumi T.

Eur J Gynaecol Oncol. 2015;36(1):49-53.

PMID:
25872334
5.

MicroRNA signatures of platinum-resistance in ovarian cancer.

Ying HC, Xu HY, Lv J, Ying TS, Yang Q.

Eur J Gynaecol Oncol. 2015;36(1):16-20.

PMID:
25872328
6.

The combination of axitinib followed by paclitaxel/carboplatin yields extended survival in advanced BRAF wild-type melanoma: results of a clinical/correlative prospective phase II clinical trial.

Algazi AP, Cha E, Ortiz-Urda SM, McCalmont T, Bastian BC, Hwang J, Pampaloni MH, Behr S, Chong K, Cortez B, Quiroz A, Coakley F, Liu S, Daud AI.

Br J Cancer. 2015 Apr 14;112(8):1326-31. doi: 10.1038/bjc.2014.541. Epub 2015 Mar 31.

PMID:
25867272
7.

[Adjuvant treatment for esophagogastric junction cancer].

Kurokawa Y, Takiguchi S, Miyazaki Y, Takahashi T, Yamasaki M, Miyata H, Nakajima K, Mori M, Doki Y.

Nihon Geka Gakkai Zasshi. 2015 Jan;116(1):50-4. Review. Japanese.

PMID:
25842814
8.

Concurrent chemo-radiation with or without induction gemcitabine, Carboplatin, and Paclitaxel: a randomized, phase 2/3 trial in locally advanced nasopharyngeal carcinoma.

Tan T, Lim WT, Fong KW, Cheah SL, Soong YL, Ang MK, Ng QS, Tan D, Ong WS, Tan SH, Yip C, Quah D, Soo KC, Wee J.

Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):952-60. doi: 10.1016/j.ijrobp.2015.01.002.

PMID:
25832687
9.

[Ovarian cancer: TC therapy].

Sugano T, Katsumata N.

Nihon Rinsho. 2015 Feb;73 Suppl 2:604-8. Japanese. No abstract available.

PMID:
25831831
10.

The South West Area Mesothelioma and Pemetrexed trial: a multicentre prospective observational study evaluating novel markers of chemotherapy response and prognostication.

Hooper CE, Lyburn ID, Searle J, Darby M, Hall T, Hall D, Morley A, White P, Rahman NM, De Winton E, Clive A, Masani V, Arnold DT, Dangoor A, Guglani S, Jankowska P, Lowndes SA, Harvey JE, Braybrooke JP, Maskell NA.

Br J Cancer. 2015 Mar 31;112(7):1175-82. doi: 10.1038/bjc.2015.62.

11.

The effect of chemotherapy on health-related quality of life in mesothelioma: results from the SWAMP trial.

Arnold DT, Hooper CE, Morley A, White P, Lyburn ID, Searle J, Darby M, Hall T, Hall D, Rahman NM, De Winton E, Clive A, Masani V, Dangoor A, Guglani S, Jankowska P, Lowndes SA, Harvey JE, Braybrooke JP, Maskell NA.

Br J Cancer. 2015 Mar 31;112(7):1183-9. doi: 10.1038/bjc.2015.77.

12.

Long-term platinum retention after platinum-based chemotherapy in testicular cancer survivors: a 20-year follow-up study.

Hjelle LV, Gundersen PO, Oldenburg J, Brydøy M, Tandstad T, Wilsgaard T, Fosså SD, Bremnes RM, Haugnes HS.

Anticancer Res. 2015 Mar;35(3):1619-25.

PMID:
25750319
13.

Checkpoint blockade immunotherapy for cancer comes of age.

Brower V.

J Natl Cancer Inst. 2015 Mar 5;107(3). pii: djv069. doi: 10.1093/jnci/djv069. Print 2015 Mar. No abstract available.

PMID:
25745014
14.

Advanced thymic cancer treated with carboplatin and paclitaxel in a patient undergoing hemodialysis.

Miura S, Kagamu H, Sakai T, Nozaki K, Asakawa K, Moro H, Okajima M, Watanabe S, Yamamoto S, Iino N, Goto S, Kazama JJ, Yoshizawa H, Narita I.

Intern Med. 2015;54(1):55-8. doi: 10.2169/internalmedicine.54.3484. Epub 2015 Jan 1.

15.

Prognostic value of ERCC1, RRM1, and TS proteins in patients with resected non-small cell lung cancer.

He YW, Zhao ML, Yang XY, Zeng J, Deng QH, He JX.

Cancer Chemother Pharmacol. 2015 Apr;75(4):861-7. doi: 10.1007/s00280-015-2714-y. Epub 2015 Mar 3.

PMID:
25732635
16.

[A case of primary peritoneal carcinoma successfully treated using Paclitaxel and Carboplatin chemotherapy].

Takagi K, Tamura A, Hayasaka J, Watanabe A, Okamoto E, Kusano-Kitazume A, Kondo M, Shibayama T, Suenobu Y, Ohtaka Y, Akita H, Tei S.

Gan To Kagaku Ryoho. 2014 Nov;41(12):2490-2. Japanese.

PMID:
25731567
17.

[A case of Carboplatin and pemetrexed combination chemotherapy for synchronous double cancers of hepatocellular carcinoma and primary lung cancer].

Okamoto E, Sato J, Sema M, Hayasaka J, Watanabe A, Takagi K, Kusano-Kitazume A, Tamura A, Kondo M, Sakuranaka H, Ochi J, Hanada S, Tanaka M, Akita H, Tei S, Ichioka M, Shibayama T.

Gan To Kagaku Ryoho. 2014 Nov;41(12):2154-6. Japanese.

PMID:
25731454
18.

Gemcitabine + platinum combination chemotherapy in patients with metastatic cancer who suffer from severe and irreversible hepatic impairment: a single center experience.

Sezer A, Sümbül AT, Abali H, Mertsoylu H, Muallaoğlu S, Köse F, Ozyilkan O.

Hepatogastroenterology. 2014 Oct;61(135):1895-900.

PMID:
25713885
19.

The added value of bevacizumab concomitantly administered with carboplatin versus carboplatin alone in patients with recurrent glioblastomas.

Kaloshi G, Diamandi P, Cakani B, Brace G, Rroji A, Petrela M.

Tumori. 2015 Jan-Feb;101(1):41-5. doi: 10.5301/tj.5000210. Epub 2015 Feb 11.

PMID:
25702676
20.

Prolonged response to aflibercept in ovarian cancer relapse: a case report.

Redondo A, Castelo B, Pinto A, Zamora P, Espinosa E.

Tumori. 2015 Mar 20;101(1):e29-31. doi: 10.5301/tj.5000202.

PMID:
25702661
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk